Dr Reddys Laboratories RDY Peer Comparison

NYSE RDY
$11.73 -0.15 (-1.30%)
As of: Sep 10, 2026 · 12:58 PM EDT
Peer Comparison

300 Comparable Companies

Industry Generic Drugs

Dr Reddys Laboratories Ltd (RDY) is the 53rd largest of 300 Generic Drugs companies by market capitalisation, at 9.76 Bn, behind Praxis Precision Medicines, Inc. at 9.89 Bn. It trades on a P/E of 773.91, 3,606% above the peer median of 20.88. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 TEVA Teva Pharmaceutical Industries Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 42.18 Bn 60.60 2.44 38.52 Bn
2 VTRS Viatris Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 18.99 Bn -46.23 1.29 18.10 Bn
3 RDY Dr Reddys Laboratories Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 9.76 Bn 773.91 2.66 9.59 Bn
4 AMRX Amneal Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 5.40 Bn 25.08 1.73 5.27 Bn
5 BHC Bausch Health Companies Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2.09 0.21 0.45 Bn
6 ALVO Alvotech primary H-04 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -5.49 4.46 1.39 Bn
7 ANIP Ani Pharmaceuticals Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 1.49 Bn 13.81 1.52 1.13 Bn
8 AMPH Amphastar Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 12.21 1.40 0.73 Bn
9 FENC Fennec Pharmaceuticals Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -88.35 7.29 0.35 Bn
10 RDHL RedHill Biopharma Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -434.89 37.17 0.17 Bn
11 NTRB NutriBand Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -10.97 47.20 0.07 Bn
12 BGM BGM Group Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
13 ETST Earth Science Tech, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 6.76 0.72 0.02 Bn
14 NXPL NextPlat Corp primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.47 0.50 0.01 Bn
15 AEON AEON Biopharma, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.32 — 0.01 Bn
16 COSM Cosmos Health Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 0.21 0.01 Bn
17 SCNX Scienture Holdings, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.90 35.15 0.01 Bn
18 PMHS Polomar Health Services, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.59 1.78 0.01 Bn
19 SXTP 60 Degrees Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.39 2.32 0.00 Bn
20 SBFM Sunshine Biopharma Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.26 0.04 -0.01 Bn
21 QNRX Quoin Pharmaceuticals, Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
22 PRFX PRF Technologies Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 53.74 -0.01 Bn
23 GRMLW Greenland Mines Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn
24 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 641.02 Bn 30.47 6.55 620.27 Bn
25 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 445.75 Bn 70.58 6.92 439.18 Bn
26 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 357.52 Bn 112.82 5.37 350.38 Bn
27 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 223.81 Bn 31.79 4.83 219.75 Bn
28 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 206.09 Bn 23.57 5.41 192.10 Bn
29 ABT Abbott Laboratories secondary H-06 Medical Devices and Diagnostics HG-02 181.10 Bn 33.38 3.89 175.50 Bn
30 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 179.75 Bn -62.09 5.90 176.57 Bn
31 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 156.58 Bn 35.85 2.46 144.88 Bn
32 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 131.11 Bn 29.76 10.42 123.26 Bn
33 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 81.77 Bn 18.89 5.26 73.78 Bn
34 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 60.45 Bn 35.24 11.57 55.27 Bn
35 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.60 Bn -17.01 24.06 48.46 Bn
36 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.14 Bn 11.19 0.97 44.75 Bn
37 IQV Iqvia Holdings Inc. secondary H-11 Pharma Services HG-03 42.90 Bn 32.50 2.53 40.82 Bn
38 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 33.36 Bn 43.07 6.94 30.06 Bn
39 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.72 Bn 38.01 3.16 30.44 Bn
40 ZTS Zoetis Inc. secondary H-05 Pharmaceuticals and Biotechnology HG-01 30.55 Bn 9.34 3.21 28.87 Bn
41 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 29.09 Bn -19.60 2,662.91 29.09 Bn
42 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.62 Bn -31.55 24.27 26.46 Bn
43 LH Labcorp Holdings Inc. secondary H-17 Healthcare Providers HG-04 25.42 Bn 25.33 1.77 25.28 Bn
44 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 24.61 Bn 15.26 4.23 20.07 Bn
45 WST West Pharmaceutical Services Inc secondary H-07 Medical Devices and Diagnostics HG-02 23.58 Bn 42.93 7.09 23.15 Bn
46 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.26 Bn -13.65 7.52 9.61 Bn
47 IFF International Flavors & Fragrances Inc secondary M-02 Chemicals MG-01 21.41 Bn 73.32 2.15 20.84 Bn
48 GH Guardant Health, Inc. secondary H-17 Healthcare Providers HG-04 21.37 Bn -47.13 18.06 20.32 Bn
49 STE STERIS plc secondary H-06 Medical Devices and Diagnostics HG-02 20.74 Bn 25.66 3.43 20.26 Bn
50 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 17.69 Bn 20.88 2.08 17.28 Bn
51 MEDP Medpace Holdings, Inc. secondary H-11 Pharma Services HG-03 16.49 Bn 33.55 5.93 15.99 Bn
52 LDOS Leidos Holdings, Inc. secondary I-02 Aerospace and Defense IG-01 16.38 Bn 11.74 0.93 15.63 Bn
53 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 18.24 11.15 14.87 Bn
54 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.80 Bn 22.40 4.68 15.42 Bn
55 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.43 Bn -48.38 12.02 14.59 Bn
56 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.19 Bn 16.14 3.30 13.57 Bn
57 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.45 Bn 16.79 5.93 13.61 Bn
58 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.33 Bn -20.71 20.09 13.61 Bn
59 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.31 Bn — — 12.62 Bn
60 CRL Charles River Laboratories International, Inc. secondary H-11 Pharma Services HG-03 13.15 Bn -55.34 3.29 12.96 Bn
61 ICLR Icon Plc secondary H-11 Pharma Services HG-03 12.82 Bn 16.48 1.55 11.89 Bn
62 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.60 Bn 172.64 3.70 11.72 Bn
63 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 30.41 7.56 12.34 Bn
64 BAX Baxter International Inc secondary H-07 Medical Devices and Diagnostics HG-02 12.50 Bn 543.41 1.13 10.35 Bn
65 CORT Corcept Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 12.16 Bn 224.33 14.63 11.85 Bn
66 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.86 Bn -43.58 17.71 10.26 Bn
67 DVA Davita Inc. secondary H-14 Healthcare Providers HG-04 11.78 Bn 10.12 0.84 11.09 Bn
68 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
69 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.84 Bn -70.50 13.96 10.52 Bn
70 TEM Tempus AI, Inc. secondary H-17 Healthcare Providers HG-04 10.65 Bn -42.85 7.44 9.83 Bn
71 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
72 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.03 Bn 18.72 3.19 9.43 Bn
73 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.89 Bn -25.93 — 9.13 Bn
74 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn 87.15 34.12 9.62 Bn
75 PODD Insulet Corp secondary H-06 Medical Devices and Diagnostics HG-02 9.37 Bn 24.96 3.07 8.84 Bn
76 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.15 Bn -43.10 10.47 7.09 Bn
77 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.66 Bn -46.01 — 8.66 Bn
78 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.56 Bn -8.10 — 8.56 Bn
79 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -8.16 48.86 7.74 Bn
80 TWST Twist Bioscience Corp secondary H-10 Medical Devices and Diagnostics HG-02 7.99 Bn -58.47 18.51 7.83 Bn
81 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.75 Bn 17.54 9.69 7.07 Bn
82 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.73 Bn -14.36 — 7.73 Bn
83 ALKS Alkermes plc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 7.62 Bn 115.18 4.57 6.96 Bn
84 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
85 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.41 Bn -41.42 — 7.41 Bn
86 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.30 Bn -18.08 — 7.30 Bn
87 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.00 Bn -33.28 29.16 6.67 Bn
88 CAI Caris Life Sciences, Inc. secondary H-17 Healthcare Providers HG-04 6.77 Bn 64.42 6.84 5.98 Bn
89 LNTH Lantheus Holdings, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 6.55 Bn 23.81 4.21 5.96 Bn
90 HIMS Hims & Hers Health, Inc. secondary H-16 Healthcare Providers HG-04 6.44 Bn -45.35 2.50 5.60 Bn
91 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.35 Bn -708.81 4,560.40 6.35 Bn
92 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.32 Bn -38.77 1.19 5.94 Bn
93 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -28.12 1,012.15 6.30 Bn
94 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -7.32 10.19 5.86 Bn
95 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.00 Bn 43.30 13.31 5.72 Bn
96 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn 73.56 7.06 5.41 Bn
97 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.89 Bn -16.24 — 5.89 Bn
98 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn 29.35 19.92 4.43 Bn
99 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -15.63 — 5.78 Bn
100 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.72 Bn — — 3.99 Bn
101 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.67 Bn -32.22 1,129.84 5.50 Bn
102 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.60 Bn 14.63 5.55 3.37 Bn
103 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.97 Bn -17.30 — 4.97 Bn
104 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.72 Bn -21.56 — 4.72 Bn
105 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.99 Bn -7.80 1,106.53 3.99 Bn
106 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.98 Bn — — 3.58 Bn
107 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
108 ADPT Adaptive Biotechnologies Corp secondary H-17 Healthcare Providers HG-04 3.87 Bn -96.02 12.55 3.52 Bn
109 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.82 Bn -13.35 368.85 3.82 Bn
110 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -7.05 — 3.77 Bn
111 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.65 Bn -17.48 11.25 3.36 Bn
112 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -29.55 — 3.59 Bn
113 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.58 Bn 17.15 0.59 2.45 Bn
114 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.53 Bn -34.48 65.58 2.51 Bn
115 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -15.95 15.00 2.68 Bn
116 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.42 Bn -7.45 29.27 2.72 Bn
117 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.31 Bn -20.08 49.96 3.31 Bn
118 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 107.23 6.58 2.82 Bn
119 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -9.77 19,011.68 3.00 Bn
120 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -5.81 — 3.00 Bn
121 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.38 — 2.96 Bn
122 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -10.73 593.06 2.38 Bn
123 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.86 Bn -14.20 — 2.86 Bn
124 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn -8.32 77.26 2.40 Bn
125 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.74 Bn -14.58 6.10 2.04 Bn
126 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.60 Bn 4.52 0.06 -3.20 Bn
127 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -79.79 — 2.59 Bn
128 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
129 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -8.07 46.95 2.44 Bn
130 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.42 Bn -28.47 3.08 2.05 Bn
131 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -6.02 — 2.41 Bn
132 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
133 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -20.04 43.62 1.70 Bn
134 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 13.31 2.47 1.57 Bn
135 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.32 Bn -5.81 32.67 2.32 Bn
136 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.27 Bn -153.12 9.02 2.15 Bn
137 NEO Neogenomics Inc secondary H-17 Healthcare Providers HG-04 2.26 Bn -43.65 2.96 2.12 Bn
138 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.26 Bn -11.39 — 1.89 Bn
139 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.18 Bn -20.12 12.81 2.18 Bn
140 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -34.73 11.46 2.05 Bn
141 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -15.76 1.09 1.37 Bn
142 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.92 4.19 2.01 Bn
143 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn -5.45 3.92 1.74 Bn
144 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.17 0.33 0.59 Bn
145 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 6.62 6.68 1.64 Bn
146 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -15.08 103.44 2.07 Bn
147 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -8.47 — 2.05 Bn
148 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.83 20.21 1.99 Bn
149 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -4.76 1,978.57 1.98 Bn
150 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.95 Bn -13.01 52.57 1.68 Bn
151 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -4.90 — 1.93 Bn
152 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -9.27 69.79 1.63 Bn
153 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -3.22 — 1.62 Bn
154 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -11.18 17.40 1.45 Bn
155 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -7.12 5.91 1.79 Bn
156 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -13.07 1,341.33 1.74 Bn
157 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
158 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.78 17.34 1.71 Bn
159 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -94.41 3.97 0.83 Bn
160 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -3.27 30.92 1.14 Bn
161 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.34 — 1.13 Bn
162 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -9.11 6.54 1.10 Bn
163 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -26.50 — 1.29 Bn
164 FTRE Fortrea Holdings Inc. secondary H-11 Pharma Services HG-03 1.60 Bn -18.77 0.60 1.43 Bn
165 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 525.54 1.60 Bn
166 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -8.51 — 1.58 Bn
167 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
168 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -65.57 7.86 1.28 Bn
169 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn -184.54 897.61 1.54 Bn
170 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.11 3.66 0.79 Bn
171 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -9.11 20.12 1.21 Bn
172 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -9.91 — 1.47 Bn
173 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -13.82 73.27 1.47 Bn
174 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.16 2.04 1.17 Bn
175 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.35 50.09 0.81 Bn
176 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.42 Bn -26.17 5.49 1.01 Bn
177 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -8.49 — 1.39 Bn
178 HROW Harrow, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -41.04 4.98 1.29 Bn
179 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -16.38 — 1.37 Bn
180 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.67 — 1.35 Bn
181 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 78.44 34.84 1.34 Bn
182 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -8.42 — 1.32 Bn
183 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -4.43 — 1.31 Bn
184 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -10.77 835.29 1.10 Bn
185 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -6.35 — 1.30 Bn
186 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.74 0.75 Bn
187 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -1.33 — 1.22 Bn
188 IART Integra Lifesciences Holdings Corp secondary H-06 Medical Devices and Diagnostics HG-02 1.20 Bn -166.37 0.73 0.93 Bn
189 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.19 — 0.99 Bn
190 MGTX MeiraGTx Holdings plc secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 7.15 2.94 1.04 Bn
191 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -26.96 2.99 1.06 Bn
192 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.59 — 1.16 Bn
193 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -11.28 48.23 1.16 Bn
194 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -19.14 — 1.10 Bn
195 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.49 22.28 0.63 Bn
196 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.62 5.55 0.92 Bn
197 MRVI Maravai Lifesciences Holdings, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 1.00 Bn -7.38 4.81 0.93 Bn
198 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -3.70 — 0.45 Bn
199 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -118.02 — 0.98 Bn
200 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -4.74 14.68 0.59 Bn
201 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -68.07 — 0.89 Bn
202 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -13.69 3.78 0.62 Bn
203 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -16.32 2.02 0.63 Bn
204 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
205 LXRX Lexicon Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -13.99 21.21 0.69 Bn
206 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.69 3.13 0.77 Bn
207 QDEL QuidelOrtho Corp secondary H-08 Medical Devices and Diagnostics HG-02 0.84 Bn — — 0.72 Bn
208 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn -4.06 — 0.83 Bn
209 AVR Anteris Technologies Global Corp. secondary H-06 Medical Devices and Diagnostics HG-02 0.81 Bn -9.76 361.66 0.81 Bn
210 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -15.00 809.82 0.81 Bn
211 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.77 — 0.78 Bn
212 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -9.77 94.56 0.78 Bn
213 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -6.54 8.62 0.62 Bn
214 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -9.83 40.73 0.42 Bn
215 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -119.85 2.24 0.58 Bn
216 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 5.24 0.49 Bn
217 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn -5.98 — 0.70 Bn
218 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -6.03 — 0.59 Bn
219 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.94 1.67 0.57 Bn
220 AQST Aquestive Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -8.30 12.01 0.55 Bn
221 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.20 1,023.84 0.56 Bn
222 EVO Evotec SE secondary H-11 Pharma Services HG-03 0.63 Bn — — 0.20 Bn
223 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.62 Bn 4.96 1.67 0.37 Bn
224 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.20 — 0.61 Bn
225 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -12.39 — 0.60 Bn
226 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.65 573.03 0.42 Bn
227 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -337,225.82 — 0.59 Bn
228 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 466.79 7.76 0.26 Bn
229 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.77 3.42 0.43 Bn
230 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 60.41 1.77 -0.01 Bn
231 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.30 — 0.56 Bn
232 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.59 2.31 0.30 Bn
233 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -6.33 — 0.54 Bn
234 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -15.11 329.30 0.40 Bn
235 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.64 13.40 0.46 Bn
236 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.39 — 0.51 Bn
237 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
238 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -7.15 21.50 0.20 Bn
239 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.81 8.71 0.19 Bn
240 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.56 2.02 0.37 Bn
241 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.62 — 0.45 Bn
242 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.46 Bn -5.63 330.55 0.46 Bn
243 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.87 2.41 0.39 Bn
244 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.51 — 0.46 Bn
245 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.28 — 0.23 Bn
246 RGNX REGENXBIO Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.55 2.39 0.35 Bn
247 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -15.20 — 0.44 Bn
248 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -4.29 12.40 0.18 Bn
249 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.33 — 0.43 Bn
250 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.08 — 0.42 Bn
251 DNA Ginkgo Bioworks Holdings, Inc. secondary H-11 Pharma Services HG-03 0.42 Bn -1.45 3.76 0.34 Bn
252 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.41 Bn 6.85 — 0.41 Bn
253 CLPT ClearPoint Neuro, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.41 Bn -13.94 9.60 0.38 Bn
254 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.22 13.70 0.21 Bn
255 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.18 39.59 0.20 Bn
256 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.19 37.98 0.39 Bn
257 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -2.23 — 0.24 Bn
258 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.80 — 0.39 Bn
259 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
260 WDH Waterdrop Inc. secondary F-16 Insurance FG-04 0.37 Bn 4.75 0.51 0.19 Bn
261 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -5.87 5.67 0.18 Bn
262 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -1.16 128.62 0.18 Bn
263 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.20 0.43 0.25 Bn
264 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.28 76.54 0.25 Bn
265 DMAC DiaMedica Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -10.31 — 0.34 Bn
266 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.26 — 0.34 Bn
267 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -2.81 — 0.34 Bn
268 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.45 — 0.32 Bn
269 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.84 8.65 0.25 Bn
270 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -7.65 5.39 0.15 Bn
271 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.80 — 0.32 Bn
272 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.97 99.70 0.31 Bn
273 EBS Emergent BioSolutions Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.70 0.39 0.16 Bn
274 IMRX Immuneering Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.08 — 0.30 Bn
275 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.58 3.27 0.13 Bn
276 EMBC Embecta Corp. secondary H-06 Medical Devices and Diagnostics HG-02 0.29 Bn 3.31 0.28 0.07 Bn
277 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.13 2.17 0.29 Bn
278 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.75 6.18 0.23 Bn
279 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.42 — 0.28 Bn
280 BDSX Biodesix Inc secondary H-17 Healthcare Providers HG-04 0.28 Bn -9.59 2.67 0.25 Bn
281 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.01 — 0.27 Bn
282 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -5.07 12.40 0.27 Bn
283 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.64 58.21 0.27 Bn
284 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.42 4.41 0.27 Bn
285 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.21 — 0.26 Bn
286 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.16 — 0.26 Bn
287 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -8.58 1.16 0.10 Bn
288 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.53 — 0.25 Bn
289 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.00 4.49 0.09 Bn
290 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -15.70 1.51 0.14 Bn
291 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 63.27 — 0.15 Bn
292 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.04 — 0.25 Bn
293 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.50 — 0.13 Bn
294 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -4.86 57.71 0.24 Bn
295 OSUR Orasure Technologies Inc secondary H-08 Medical Devices and Diagnostics HG-02 0.23 Bn — 2,339.78 0.03 Bn
296 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.81 20.18 0.23 Bn
297 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.03 0.00 -10.83 Bn
298 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.30 — 0.23 Bn
299 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 3.11 0.14 Bn
300 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 96.08 0.11 Bn